Breast cancer after bilateral risk-reducing mastectomy

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Breast cancer after bilateral risk-reducing mastectomy. / Skytte, A-B; Crüger, Dorthe Gylling; Gerster, M; Laenkholm, A-V; Lang, C; Brøndum-Nielsen, K; Andersen, M K; Sunde, Lone E. M.; Kølvraa, Steen; Gerdes, A-M.

I: Clinical Genetics, Bind 79, Nr. 5, 2011, s. 431-7.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Skytte, A-B, Crüger, DG, Gerster, M, Laenkholm, A-V, Lang, C, Brøndum-Nielsen, K, Andersen, MK, Sunde, LEM, Kølvraa, S & Gerdes, A-M 2011, 'Breast cancer after bilateral risk-reducing mastectomy', Clinical Genetics, bind 79, nr. 5, s. 431-7. https://doi.org/10.1111/j.1399-0004.2010.01604.x

APA

Skytte, A-B., Crüger, D. G., Gerster, M., Laenkholm, A-V., Lang, C., Brøndum-Nielsen, K., Andersen, M. K., Sunde, L. E. M., Kølvraa, S., & Gerdes, A-M. (2011). Breast cancer after bilateral risk-reducing mastectomy. Clinical Genetics, 79(5), 431-7. https://doi.org/10.1111/j.1399-0004.2010.01604.x

Vancouver

Skytte A-B, Crüger DG, Gerster M, Laenkholm A-V, Lang C, Brøndum-Nielsen K o.a. Breast cancer after bilateral risk-reducing mastectomy. Clinical Genetics. 2011;79(5):431-7. https://doi.org/10.1111/j.1399-0004.2010.01604.x

Author

Skytte, A-B ; Crüger, Dorthe Gylling ; Gerster, M ; Laenkholm, A-V ; Lang, C ; Brøndum-Nielsen, K ; Andersen, M K ; Sunde, Lone E. M. ; Kølvraa, Steen ; Gerdes, A-M. / Breast cancer after bilateral risk-reducing mastectomy. I: Clinical Genetics. 2011 ; Bind 79, Nr. 5. s. 431-7.

Bibtex

@article{810bc56f9d2c44f59ef3dda69e287562,

title = "Breast cancer after bilateral risk-reducing mastectomy",

abstract = "This study aims to evaluate the incidence of breast cancer after risk-reducing mastectomy (RRM) in healthy BRCA mutation carriers. This study is a long-term follow-up of 307 BRCA mutation carriers of whom 96 chose RRM. None of the study participants had a previous history of breast or ovarian cancer nor had they undergone RRM or risk-reducing bilateral salpingo-oophorectomy (BSO) prior to the time of BRCA testing. The annual incidence of post-mastectomy breast cancer was 0.8% compared with 1.7% in the non-operated group. Implications of these findings in relation to genetic counseling and future management are discussed.",

author = "A-B Skytte and Cr{\"u}ger, {Dorthe Gylling} and M Gerster and A-V Laenkholm and C Lang and K Br{\o}ndum-Nielsen and Andersen, {M K} and Sunde, {Lone E. M.} and Steen K{\o}lvraa and A-M Gerdes",

note = "{\textcopyright} 2011 John Wiley & Sons A/S.",

year = "2011",

doi = "10.1111/j.1399-0004.2010.01604.x",

language = "English",

volume = "79",

pages = "431--7",

journal = "Clinical Genetics",

issn = "0009-9163",

publisher = "Wiley-Blackwell",

number = "5",

}

RIS

TY - JOUR

T1 - Breast cancer after bilateral risk-reducing mastectomy

AU - Skytte, A-B

AU - Crüger, Dorthe Gylling

AU - Gerster, M

AU - Laenkholm, A-V

AU - Lang, C

AU - Brøndum-Nielsen, K

AU - Andersen, M K

AU - Sunde, Lone E. M.

AU - Kølvraa, Steen

AU - Gerdes, A-M

PY - 2011

Y1 - 2011

N2 - This study aims to evaluate the incidence of breast cancer after risk-reducing mastectomy (RRM) in healthy BRCA mutation carriers. This study is a long-term follow-up of 307 BRCA mutation carriers of whom 96 chose RRM. None of the study participants had a previous history of breast or ovarian cancer nor had they undergone RRM or risk-reducing bilateral salpingo-oophorectomy (BSO) prior to the time of BRCA testing. The annual incidence of post-mastectomy breast cancer was 0.8% compared with 1.7% in the non-operated group. Implications of these findings in relation to genetic counseling and future management are discussed.

AB - This study aims to evaluate the incidence of breast cancer after risk-reducing mastectomy (RRM) in healthy BRCA mutation carriers. This study is a long-term follow-up of 307 BRCA mutation carriers of whom 96 chose RRM. None of the study participants had a previous history of breast or ovarian cancer nor had they undergone RRM or risk-reducing bilateral salpingo-oophorectomy (BSO) prior to the time of BRCA testing. The annual incidence of post-mastectomy breast cancer was 0.8% compared with 1.7% in the non-operated group. Implications of these findings in relation to genetic counseling and future management are discussed.

U2 - 10.1111/j.1399-0004.2010.01604.x

DO - 10.1111/j.1399-0004.2010.01604.x

M3 - Journal article

C2 - 21199491

VL - 79

SP - 431

EP - 437

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 5

ER -

ID: 33504058